Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HAVN Life Sciences Inc. Proxy Solicitation & Information Statement 2022

Feb 25, 2022

47913_rns_2022-02-25_f041c176-ea2c-497d-86cb-2bf836a52296.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [63 x 63] intentionally omitted <==

February 25, 2022

Filed via SEDAR

To All Applicable Exchanges and Securities Administrators

Subject: HAVN Life Sciences Inc. (the “Issuer”) Notice of Meeting and Record Date

Dear Sir/Madam:

We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:

==> picture [468 x 147] intentionally omitted <==

----- Start of picture text ----- Meeting Type: Annual and Special MeetingMeeting Date: April 6, 2022Record Date for Notice of Meeting: March 2, 2022Record Date for Voting: March 2, 2022Beneficial Ownership Determination Date: March 2, 2022Class of Securities Entitled to Vote: Common SharesISIN: CA4196211078Meeting Location: Vancouver, BCIssuer sending proxy materials directly to NOBOs: YesIssuer paying for delivery to OBOs: NoNotice and Access for Beneficial Holders: NoNotice and Access for Registered Holders: No----- End of picture text -----

In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.

Yours truly,

ODYSSEY TRUST COMPANY

Signed “Lia Zandvliet”

Lia Zandvliet

Managing Director, Client Services